Navigation Links
University of Chicago's Graeme Bell receives international diabetes prize

Graeme Ian Bell, PhD, the Louis Block Distinguished Service Professor of Medicine and Human Genetics and an investigator in the Kovler Diabetes Center at the University of Chicago, has been awarded the Manpei Suzuki International Prize for 2012 for his pioneering work in understanding the role of genetics in the diagnosis and treatment of diabetes.

The prize, the world's largest award for diabetes research, includes a certificate of honor, a Japanese objet d'art and $150,000. Inaugurated in 2008 to commemorate the 15th anniversary of the Manpei Suzuki Diabetes Foundation, the prize honors "those who have enlightened researchers in the field of diabetes around the world with their original and excellent scientific achievements."

Bell is being recognized, according to the selection committee, for his "extensive and groundbreaking contributions over many years to many landmark discoveries in diabetes research utilizing the powerful technologies of molecular biology and genetics." He will receive the prize and present a commemorative lecture at the award ceremony in Tokyo on Feb. 5, 2013.

Bell is the second scientist from the University of Chicago to win this prestigious award in the five years it has been given. His colleague Donald F. Steiner, MD, the A.N. Pritzker Distinguished Service Professor Emeritus of Medicine and Biochemistry and Molecular Biology, received the award for 2009.

"This is a wonderful honor and a very pleasant surprise," Bell said. "I am proud to find myself among such distinguished company and pleased that work from our laboratory and our many collaborators has had an impact on the field and been recognized in this way."

Bell studies the genetics of diabetes mellitus and the biology of the insulin-secreting pancreatic beta-cell. He cloned and characterized many of the genes that are key in the regulation of glucose metabolism including insulin, glucagon, glucose transporters and many others.

Working with colleague Nancy Cox, PhD, Professor of Medicine and Human Genetics and Section Chief of Genetic Medicine at the University of Chicago, Bell discovered mutations in the genes for glucokinase and for three transcription factors that cause an early-onset form of diabetes called maturity-onset diabetes of the young. Once thought to be very rare, this form of diabetes represents up to 5 percent of cases. Correct genetic diagnosis can alter treatment and improve clinical outcome.

"Perhaps the most remarkable aspect of Graeme's research in diabetes is its scope," Cox said. "He has made fundamental discoveries, but he also wants to make sure that patients benefit quickly from those advances. He engages with scientists in health care economics to evaluate the costs and benefits of translating the research findings into routine patient care, and works with clinicians to develop protocols for that translation. Few have the ability and the drive to do basic, translational and clinical research so effectively. This is a well-deserved honor."

Bell is a key member of the University of Chicago Medicine's diabetes genetics team, whose work involves using genetics to personalize treatment targeted to a patient's specific genetic defect. Babies with diabetes provide the most dramatic example of this approach. Nearly half have diabetes due to mutations in genes. Some of these children can be treated with pills that compensate for the genetic defect, rather than with insulin shots. More than 1,500 patients and family members are now participating in genetic studies aimed at improving treatment through a better understanding of genetics.

The Manpei Suzuki Diabetes Foundation promotes research on diabetes by encouraging international contacts among young scientists. Manpei Suzuki, former chairman of the Federation of Pharmaceutical Manufacturers' Association of Japan, chairman of the Board of Directors of Sankyo Co. Ltd. and member of the Japanese House of Councilors, suffered from diabetes mellitus in the last years of his life. In keeping with his last wishes, his widow Mitsu Suzuki established a foundation to support diabetes research.

According to the foundation, "more creative basic and applied studies are required due to the rapid aging of society which will occur in the 21st century." The international exchange among researchers that the foundation supports "will help improve health care technology and develop new health care resources in Japan. This, in turn, will lead to improvements in the prevention, diagnosis, and treatment of diabetes, a disease which affects many people and can have serious consequences for their quality of life."


Contact: John Easton
University of Chicago Medical Center

Related biology news :

1. University of Houston study shows BP oil spill hurt marshes, but recovery possible
2. University of Alberta led research may have discovered how memories are encoded in our brains
3. BGI, University of Helsinki and Wuhan University sign a MOU concerning cooperation on genomics
4. Marshall University study may lead to new treatments for prostate cancer
5. University leads £6 million EU project to tackle obesity
6. A University of Tennessee professors hypothesis may be game changer for evolutionary theory
7. Life expectancy may affect when you get married, divorced, have kids: Queens University study
8. University of Toronto biologists predict extinction for organisms with poor quality genes
9. University of Minnesota invention helps advance reliability of alternative energy
10. Israel names Tel Aviv Universitys Renewable Energy Center a Center of Research Excellence
11. University of Minnesota startup offers game-changing energy solutions that reduce CO2 emissions
Post Your Comments:
Related Image:
University of Chicago's Graeme Bell receives international diabetes prize
(Date:10/12/2015)... Research and Markets ( ) ... Recognition Market by Component (Hardware & Software), Product ... Industry (Travel & Immigration, Military & Defense, & ... report to their offering. ... Market worth 3627.90 Million USD by 2020 ...
(Date:10/8/2015)... LAKE CITY , 8. Oktober 2015 ... TRCK), ein global tätiges Unternehmen des Bereiches ... einem Vertrag mit der Gefängnisbehörde Virginias (Department ... dessen Rahmen elektronische Überwachungsdienste für alle Strafen ... Derek Cassell , Präsident für den ...
(Date:10/7/2015)... NXTD ) ("NXT-ID" or the ... mobile commerce market and creator of the Wocket® smart ... long- term executive at American Express has been appointed ... ) ("NXT-ID" or the "Company"), a biometric authentication company ... of the Wocket® smart wallet announces Mr. Stanley ...
Breaking Biology News(10 mins):
(Date:10/12/2015)... cell surface marker detection market ... to a new report by Grand View Research, Inc. This ... of oncology diseases and other cell-associated disorders. --> ... USD 6.49 billion by 2022, according to a new report ... be attributed to rise in incidence of oncology diseases and ...
(Date:10/12/2015)... 2015  Patara Pharma, a clinical-stage biotechnology company ... and conditions, today announced the closing of a ... with the close of its sale of preferred ... Security Agreement with Silicon Valley Bank whereby the ... will use the funds from the financing to ...
(Date:10/12/2015)... 12, 2015 VolitionRx Limited (NYSE MKT: ... study of its NuQ ® blood-based test for early ... of Clinical Epigenetics , the official journal of the ... with Lund University, Sweden ... PhD, Professor of Surgery and Vice-Dean, Faculty of Medicine. ...
(Date:10/12/2015)... ... October 12, 2015 , ... LifeTrak , a leader in ... Zoom, the world’s first amphibious fitness tracker that seeks to meet the needs of ... accurate heart rate monitoring both in water and on land, making it ...
Breaking Biology Technology: